1WCM
12 West Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-735,000
| Closed | -$95.5M | – | 15 |
|
|
2020
Q4 | $95.5M | Hold |
735,000
| – | – | 4.1% | 7 |
|
|
2020
Q3 | $107M | Hold |
735,000
| – | – | 5.21% | 6 |
|
|
2020
Q2 | $109M | Hold |
735,000
| – | – | 5.63% | 6 |
|
|
2020
Q1 | $80M | Hold |
735,000
| – | – | 4.77% | 6 |
|
|
2019
Q4 | $84.7M | Hold |
735,000
| – | – | 5.34% | 7 |
|
|
2019
Q3 | $59.1M | Hold |
735,000
| – | – | 3.81% | 10 |
|
|
2019
Q2 | $53.3M | Hold |
735,000
| – | – | 4.01% | 10 |
|
|
2019
Q1 | $68.7M | Hold |
735,000
| – | – | 5.6% | 6 |
|
|
2018
Q4 | $53.6M | Hold |
735,000
| – | – | 5.52% | 6 |
|
|
2018
Q3 | $64.3M | Hold |
735,000
| – | – | 4.72% | 8 |
|
|
2018
Q2 | $72.4M | Buy |
735,000
+35,000
| +5% | +$3.45M | 5.97% | 7 |
|
|
2018
Q1 | $83.4M | Hold |
700,000
| – | – | 9.17% | 6 |
|
|
2017
Q4 | $88.9M | Hold |
700,000
| – | – | 10.75% | 4 |
|
|
2017
Q3 | $82.2M | Hold |
700,000
| – | – | 11.5% | 4 |
|
|
2017
Q2 | $55.8M | Hold |
700,000
| – | – | 9.45% | 5 |
|
|
2017
Q1 | $35.9M | Hold |
700,000
| – | – | 7.13% | 5 |
|
|
2016
Q4 | $26.2M | Hold |
700,000
| – | – | 4.66% | 7 |
|
|
2016
Q3 | $47.4M | Hold |
700,000
| – | – | 6.8% | 4 |
|
|
2016
Q2 | $38.8M | Buy |
700,000
+4,000
| +0.6% | +$222K | 6.26% | 4 |
|
|
2016
Q1 | $43.7M | Buy |
696,000
+45,000
| +7% | +$2.82M | 6.07% | 5 |
|
|
2015
Q4 | $61.3M | Hold |
651,000
| – | – | 8.75% | 4 |
|
|
2015
Q3 | $52.3M | Hold |
651,000
| – | – | 7.63% | 4 |
|
|
2015
Q2 | $78M | Hold |
651,000
| – | – | 8.91% | 4 |
|
|
2015
Q1 | $68M | Hold |
651,000
| – | – | 7.56% | 5 |
|
|
2014
Q4 | $63.1M | Hold |
651,000
| – | – | 7.83% | 5 |
|
|
2014
Q3 | $50.8M | Buy |
+651,000
| New | +$50.8M | 5.93% | 5 |
|